2,489
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Resveratrol improves sperm parameter and testicular apoptosis in cisplatin-treated rats: Effects on ERK1/2, JNK, and Akt pathways

ORCID Icon
Pages 236-249 | Received 24 Feb 2018, Accepted 21 Oct 2018, Published online: 03 Dec 2018

References

  • Amin A, Abraham C, Hamza A, Abdalla Z, Al-Shamsi S, Harethi S, Daoud S. 2012. A standardized extract of Ginkgo biloba neutralizes Cisplatin -mediated reproductive toxicity in rats. J Biomed Biotechnol. Article Id:362049.
  • Amin A, Hamza AA, Kambal A, Daoud S. 2008. Herbal extracts counteract cisplatin-mediated cell death in rat testis. Asian J Androl. 10(2):291–297.
  • Anderson D, Bishop JP, Garner RC, Ostrosky-Wegman P, Selby PB. 1995. Cyclophosphamide, review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res-Fund Mol M. 330(1–2):115–181.
  • Ateşşahin A, Şahna E, Türk G, Çeribaşi AO, Yılmaz S, Yüce A, Bulmuş Ö. 2006. Chemoprotective effect of melatonin against cisplatin‐induced testicular toxicity in rats. J Pineal Res. 41(1):21–27.
  • Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, et al. 2010. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci USA. 2010 Aug 31;107(35):15553–15558.
  • Baur J, Sinclair D. 2006. Therapeutic potential of resveratrol, the in vivo evidence. Nat Rev Drug Discov. 5(6):493–506.
  • Blanco-Rodriguez J, Martinez-Garcia C. 1998. Apoptosis precedes detachment of germ cells from the seminiferous epithelium after hormone suppression by short-term oestradiol treatment of rats. Int J Androl. 21(2):109–115.
  • Boekelheide K. 2005. Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr Monographs. 34:6–8.
  • Boulikas T, Vougiouka M. 2003. Cisplatin, and platinum drugs at the molecular level (Review). Oncol Rep. 10(6):1663–1682.
  • Cai Y, Fang J, Ma L, Yang L, Liu Z. 2003. Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim Biophys Acta. 1637(1):313–318.
  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282(5392): 1318–1321.
  • Chang WK, Yang KD, Chuang H, Jan JT, Shaio MF. 2002. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol. 104:151–160.
  • Cherry SM, Hunt PA, Hassold TJ. 2004. Cisplatin disrupts mammalian spermatogenesis but does not affect recombination or chromosome segregation. Mutat Res-Gen Tox En. 564(2):115–128.
  • Chirino YI, Pedraza-Chaverri J. 2009. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 61:223–242.
  • Choi BK, Choi CH, Oh HL, Kim YK. 2004. Role of ERK activation in Cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology. 25(6):915–924.
  • Clermont Y. 1972. Kinetics of spermatogenesis in mammals, seminiferous epithelium cycle and spermatogonial renewal. Physiol Rev. 52(1):198–236.
  • Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G. 2004. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Bio. 113(1):S2–S6.
  • Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B. 2002. cFLIP protein prevents tumor necrosis factor-α–mediated induction of caspase-8–dependent apoptosis in insulin-secreting βTc-Tet cells. Diabetes. 51(6):1805–1814.
  • Cullinan SB, Diehl JA. 2004. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem. 279:20108–20117.
  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91(2):231–241.
  • Delmastro DA, Li J, Vaisman A, Solle M, Chaney S. 1997. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemoth Pharm. 39(3):245–253.
  • Desoize B, Madoulet C. 2002. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hemat. 42(3):317–325.
  • Dhanasekaran D, Reddy E. 2008. JNK signaling in apoptosis. Oncogene. 27(48):6245–6251.
  • Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ. 2004. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol. 287:L774–L783.
  • dos-Santos NA, Ma R, Nm M, Dos Santos AC. 2012. Cisplatin-induced nephrotoxicity and targets of nephroprotection, an update. Arch Toxicol. 86(8):1233–1250.
  • Eid AH, Abdelkader NF, Abd El-Raouf OM, Fawzy HM, El-Denshary ES. 2016. Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats viamodulation of oxidative stress and inflammation. Arch Pharm Res. 39(12):1693–1702.
  • Eleawa SM, Alkhateeb MA, Alhashem FH, Bin-Jaliah I, Sakr HF, Elrefaey HM, Elkarib AO, Alessa RM, Haidara MA, Shatoor AS, et al. 2014. Resveratrol reverses cadmium chloride-induced testicular damage and sub-fertility by down-regulating P53 and bax and upregulating of gonadotropins and Bcl-2 gene expression. J Reprod Dev. 60(2):115–127.
  • Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E. 2012. The effect of resveratrol on the prevention of Cisplatin ototoxicity. Eur Arch Otorhinolaryngol. 269(10):2185–2188.
  • Gong J, Costanzo A, Yang HQ, Melino G, Kaelin WG, Levrero M, Wang JY. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399(6738):806–809.
  • Hamza AA, Elwy HM, Badawi AM. 2016. Fenugreek seed extract attenuates cisplatin-induced testicular damage in Wistar rats. Andrologia. 48:211–221.
  • Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, et al. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 11:619–633.
  • Haynes CM, Titus EA, Cooper AA. 2004. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell. 15:767–776.
  • Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J, Marrack P. 2003. Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci USA. 100(25):15035–15040.
  • Ilbey YO, Ozbek E, Simsek A, Otunctemur A, Cekmen M, Somay A. 2009. Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats. Fertil Steril. 92:1124–1132.
  • Jahnukainen K, Ehmcke J, Hou M, Schlatt S. 2011. Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab. 25(2):287–302.
  • Jo SK, Cho WY, Sung SA, Kim HK, Won NH. 2005. MEK inhibitor, U0126, attenuates Cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 67(2):458–466.
  • Juan ME, González-Pons E, Munuera T, Ballester J, Rodríguez-Gil JE, Planas JM. 2005. trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. J Nutr. 135(4):757–760.
  • Katoh C, Kitajima S, Saga Y, Kanno J, Horii I, Inoue T. 2002. Assessment of quantitative dual-parameter flow cytometric analysis for the evaluation of testicular toxicity using cyclophosphamide- and ethinylestradiol-treated rats. J Toxicol Sci. 27(2):87–96.
  • Keshtmand Z, Oryan S, Ghanbari A, Khazaei M. 2014. Protective effect of tribulus terrestris hydroalcoholic extract against cisplatin-induced cytotoxicity on sperm parameters in male mice. Int J Morphol. 32(2):551–557.
  • Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, Jung JS, Kim JM. 2005. Role of ERK activation in Cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol. 25(5):374–382.
  • Koksal IT, Usta M, Orhan I, Abbasoglu S, Kadıoglu A. 2003. Potential role of reactive oxygen species on testicular pathology associated with infertility. Asian J Androl. 5:95–99.
  • Koster R, Van Vugt M, Timmer-Bosscha H, Gietema JA, de Jong S. 2013. Unravelling mechanisms of Cisplatin sensitivity and resistance in testicular cancer. Expert Rev Mol Med. 15:e12.
  • Lebwohl D, Canetta R. 1998. Clinical development of platinum complexes in cancer therapy, a historical perspective, and an update. Eur J Cancer. 34(10):1522–1534.
  • Mauro C, Crescenzi E, De Mattia R, Pacifico F, Mellone S, Salzano S, de Luca C, D’Adamio L, Palumbo G, Formisano S, et al. 2006. Central role of the scafford protein TNF-receptor associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis. J Biol Chem. 281:2631–2638.
  • McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol. 21(4):1249–1259.
  • Murgu´Ia S-PJ, Perona R. 1998. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene. 16(4):533–540.
  • Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403(6765):98–103.
  • Narayana K. 2010. Cisplatin induces duplex 3ʹ overhangs and 5ʹ blunt ends in the epididymal epithelium in a Bax-dependent manner without any protection from L-ascorbic acid. Eur J Pharmacol. 641(2–3):238–245.
  • Nowak G. 2002. PKC-α and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Bio Chem. 277(45):43377–43388.
  • Omar HA, Mohamed WR, Arab HH, Arafa ES. 2016. Tangeretin alleviates cisplatin-induced acute hepatic injury in rats, targeting MAPKs and apoptosis. Plos one. 11(3):e0151649.
  • Pandya C, Pillai P, Nampoothiri LP, Bhatt N, Gupta S. 2012. Effect of lead and cadmium co-exposure on testicular steroid metabolism and antioxidant system of adult male rats. Andrologia. 44:(S1):813–822.
  • Persons DL, Yazlovitskaya E, Pelling JC. 2000. Effect of extracellular signal-regulated kinase on p53 accumulation in response to Cisplatin. J Bio Chem. 275(46):35778–35785.
  • Pogach LM, Lee Y, Giglio W, Naumoff M, Huang HF. 1989. Zinc acetate pretreatment ameliorates cisplatin-induced Sertoli cell dysfunction in Sprague-Dawley rats. Cancer Chemother Pharmacol. 24(3):177–180.
  • Prahalathan C, Selvakumar E, Varalakshmi P. 2004. Remedial effect of DL-alpha-lipoic acid against adriamycin-induced testicular lipid peroxidation. Mol Cell Biochem. 267(1–2):209–214.
  • Prestayko AW, D’Aoust JC, Issell BF, Crooke ST. 1979. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev. 6(1):17–39.
  • Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JEB. 2003. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J Neurochem. 84:982–996.
  • Rajkumar L, Srinivasan N, Balasubramanian K, Govindarajulu P. 1991. Increased degradation of dermal collagen in diabetic rats. Indian J Exp Biol. 29(11):1081–1083.
  • Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, Del Rio G, Bredesen DE, Ellerby HM. 2002. Coupling endoplasmic reticulum stress to the cell death program. an Apaf-1-independent intrinsic pathway. J Biol Chem. 277:21836–21842.
  • Reddy KP, Madhu P, Reddy PS. 2016. Protective effects of resveratrol against Cisplatin-induced testicular and epididymal toxicity in rats. Food Chem Toxicol. 91:65–72.
  • Rezvanfar MA, Rezvanfar MA, Shahverdi AR, Ahmadi A, Baeeri M, Mohammadirad A, Abdollahi M. 2013. Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles. Toxicol Appl Pharmacol. 266(3):356–365.
  • Sakamoto M, Kondo A, Kawasaki K, Goto T, Sakamoto H, Miyake K, Koyamatsu Y, Akiya T, Iwabuchi H, Muroya T, et al. 2001. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Hum Cell. 14(4):305–315.
  • Salem E, Salem N, Maarouf A, Serefoglu E, Hellstrom W. 2012. Selenium and lycopene attenuate Cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats. Urology. 79(5):1184.
  • Sharma RK, Agarwal A. 1996. Role of reactive oxygen species in male infertility. Urology. 48:835–850.
  • Sherif IO, Abdel-Aziz A, Sarhan OM. 2014. Cisplatin-induced testicular toxicity in rats: the protective effect of arjunolic acid. J Biochem Mol Toxicol. 28:515–521.
  • Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, Joo SS, Nahm SS, Kim JC, Kim YB. 2008. trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Arch Pharm Res. 31(1):83–87.
  • Siddik ZH. 2003. Cisplatin. mode of cytotoxic action and molecular basis of resistance. Oncogene. 22(47):7265–7279.
  • Sikka SC. 1996. Oxidative stress and role of antioxidants in normal and abnormal sperm function. Front Biosci. 1:78–86.
  • Singh I, Goyal Y, Ranawat P. 2017. Potential chemoprotective role of resveratrol against cisplatin induced testicular damage in mice. Chem Biol Interact. 273:200–211.
  • Soni KK, Kim HK, Choi BR, Karna KK, You JH, Cha JS, Shi YS, Lee SW, Kim CY, Park JK. 2016. Dose-dependent effects of cisplatin on the severity of testicular injury in Sprague Dawley rats: reactive oxygen species and endoplasmic reticulum stress. Drug Des Devel Ther. 10:3959–3968.
  • Surendran D, Geetha C, Mohanan P. 2012. Amelioration of melatonin on oxidative stress and genotoxic effects induced by Cisplatin in vitro. Toxicol Mech Method. 22(8):631–637.
  • Tousson E, Hafez E, Masoud A, Hassan AA. 2014. Abrogation by curcumin on testicular toxicity induced by cisplatin in rats. J Cancer Res Treat. 2(3):64–68.
  • Vawda AI. 1994. Effect of testosterone on Cisplatin-induced testicular damage. Arch Andrology. 32(1):53–57.
  • Wang D, Lippard SJ. 2005. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 4(4):307–320.
  • Wang X, Martindale J, Holbrook N. 2000. Requirement for ERK activation in Cisplatin-induced apoptosis. JBiol Chem. 275(50):39435–39443.
  • Wang X, Sharma RK, Sikka SC, Thomas AJ, Falcone T, Agarwal A. 2003. Oxidative stress is associated with increased apoptosis leading to spermatozoa DNA damage in patients with male factor infertility. Fertil and Steril. 80(3):531–535.
  • Waseem M, Bhardwaj M, Tabassum H, Raisuddin S, Parvez S. 2015. Cisplatin hepatotoxicity mediated by mitochondrial stress. Drug ChemToxicol. 38(4):452–459.
  • Wolter F, Ulrich S, Stein J. 2004. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: the key role of polyamines? J Nutr. 134(12):3219–3222.
  • Yan W, Samson M, Jégou B, Toppari J. 2000. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol. 14(5):682–699.
  • Yao X, Panichpisal K, Kurtzman N, Nugent K. 2007. Cisplatin nephrotoxicity: a review. Am J Med Sci. 334:115–124.
  • Yeh PY, Chuang SE, Yeh KH, Song YC, Ea CK, Cheng AL. 2002. Increase of the resistance of human cervical carcinoma cells to Cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation. Biochem Pharmacol. 63(8):1423–1430.
  • Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I. 2007. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-κB signaling pathways. Biochem Bioph Res Co. 360(1):263–268.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.